News By Tag
* Cartilage Repair
* Orthopedic Instruments
* Repair Implants
* More Tags...
News By Place
Shukla Medical, Inc Currently Developing Cartilage Repair Disk
Piscataway, New Jersey – March 17, 2011- Shukla Medical, Inc announced today a licensing agreement with Kytogenics Pharmaceuticals, Inc for exclusive rights to Kytogenics cartilage repair technology
The breakdown of cartilage in joints and chondral defects caused by articular cartilage injury are the most common causes of osteoarthritis. In 2005 the prevalence of osteoarthritis in the U.S. was an estimated 45 million people of which 14.5 million received medical treatment. Moreover, it is estimated that by 2030, with the aging of the baby boomer generation, the number of cases of osteoarthritis is expected to increase to 65 million.1 Due to the limited 10-15 year life span of metal implants and the risk of implant failure, there is an ever-growing need for alternative treatments.
"Shukla's resorbable cartilage repair implants will satisfy the current demand for less invasive surgical procedures and more effective products," stated Marina P. Zazanis, President/CEO of Kytogenics. "We at Kytogenics are most excited that our technology will be used to develop such innovative orthopedic products."
About Shukla Medical, Inc.
Shukla Medical is a medical device manufacturer focused on developing innovative solutions to the problems and challenges faced by Orthopedic Surgeons in the OR and patients in there everyday lives. Today, Shukla Medical is recognized as the market leader in orthopedic hardware extraction systems. Shukla Medical’s offices, manufacturing facilities and research laboratories are located in Piscataway, NJ. For more information about Shukla Medical, please visit www.ShuklaMedical.com.
About Kytogenics Pharmaceuticals, Inc.
Kytogenics is a Medical Device/Drug Delivery company developing effective products for inadequately treated medical conditions, focusing its product development on the prevention, treatment and healing of diseases and conditions using its proprietary chitosan derivative technology. The company obtained a 510-K clearance for its Hydrophilic Wound Dressing and is currently developing additional medical device and drug delivery products in the fields of hospital-acquired infections, wound care, ophthalmic, inflammatory bowel disease and interstitial cystitis. Kytogenics' corporate offices are located in Chatham, NJ and its research lab is in Dartmouth, Nova Scotia. For more information about Kytogenics Pharmaceuticals, please visit www.kytogenics.com.
# # #
Shukla Medical is dedicated to meeting the needs of the medical industry by providing world class products & services.Shukla Medical’s focus is on developing innovative solutions to problems and challenges facing the Orthopedic Surgeon in the OR today.